Smith & Nephew SNATS ROE 2006-2018 | SNN

Current and historical return on equity (ROE) values for Smith & Nephew SNATS (SNN) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Smith & Nephew SNATS ROE for the three months ending December 31, 2018 was 0.00%.
Smith & Nephew SNATS ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-12-31 $0.00B $4.87B 0.00%
2018-06-30 $0.00B $4.64B 0.00%
2017-12-31 $0.00B $4.64B 0.00%
2017-06-30 $0.00B $4.20B 0.00%
2016-12-31 $0.16B $3.96B 4.00%
2015-12-31 $0.26B $3.97B 6.52%
2015-06-30 $0.35B $4.05B 8.63%
2014-12-31 $0.50B $4.04B 12.20%
2014-09-30 $0.50B $4.02B 12.24%
2014-06-30 $0.52B $4.16B 12.81%
2014-03-31 $0.56B $4.22B 14.01%
2013-12-31 $0.56B $4.05B 14.07%
2013-09-30 $0.54B $3.91B 13.71%
2013-06-30 $0.55B $3.90B 14.26%
2013-03-31 $0.71B $3.95B 18.91%
2012-12-31 $0.73B $3.88B 20.06%
2012-09-30 $0.73B $3.64B 21.01%
2012-06-30 $0.73B $3.56B 21.91%
2012-03-31 $0.59B $3.45B 18.30%
2011-12-31 $0.58B $3.19B 18.80%
2011-09-30 $0.62B $3.06B 20.86%
2011-06-30 $0.63B $3.13B 22.06%
2011-03-31 $0.61B $3.00B 23.17%
2010-12-31 $0.62B $2.77B 25.14%
2010-09-30 $0.56B $2.48B 24.41%
2010-06-30 $0.55B $2.31B 25.31%
2010-03-31 $0.53B $2.23B 25.71%
2009-12-31 $0.47B $2.18B 24.28%
2009-09-30 $0.46B $2.01B 25.17%
2009-06-30 $0.41B $1.88B 22.95%
2009-03-31 $0.39B $1.71B 22.33%
2008-12-31 $0.38B $1.70B 21.17%
2008-09-30 $0.36B $1.77B 20.05%
2008-06-30 $0.30B $1.81B 16.36%
2008-03-31 $0.31B $1.81B 16.04%
2007-12-31 $0.32B $1.82B 15.73%
2007-09-30 $0.36B $1.91B 16.92%
2007-06-30 $0.44B $2.16B 20.33%
2007-03-31 $0.42B $2.16B 20.15%
2006-12-31 $0.75B $2.17B 36.93%
2006-09-30 $0.70B $2.07B 37.12%
2006-06-30 $0.67B $2.01B 38.78%
2006-03-31 $0.67B $1.89B 42.18%
2005-12-31 $0.34B $1.57B 23.26%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $17.634B $4.904B
Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $140.623B 27.80
Medtronic (MDT) Ireland $123.520B 18.06
Stryker (SYK) United States $73.875B 27.09
Boston Scientific (BSX) United States $52.874B 25.78
Baxter (BAX) United States $40.209B 25.72
Zimmer Biomet Holdings (ZBH) United States $26.486B 16.96
Canopy Growth (CGC) Canada $15.407B 0.00
ResMed (RMD) United States $14.469B 27.44
Aurora Cannabis (ACB) Canada $9.687B 68.36
Bio-Rad Laboratories (BIO) United States $9.455B 53.94
Hill-Rom Holdings (HRC) United States $7.140B 22.08
Perrigo (PRGO) Ireland $6.601B 10.70
Insulet (PODD) United States $6.039B 2037.40
GW Pharmaceuticals (GWPH) United Kingdom $5.309B 0.00
ICU Medical (ICUI) United States $4.841B 30.14
Haemonetics (HAE) United States $4.496B 39.88
Hutchison China MediTech (HCM) China $3.961B 0.00
Agios Pharmaceuticals (AGIO) United States $3.830B 0.00
Neogen (NEOG) United States $3.332B 51.18
NuVasive (NUVA) United States $2.927B 25.53
Quidel (QDEL) United States $2.672B 24.11
Aphria (APHA) $2.518B 111.78
National Vision Holdings (EYE) United States $2.327B 45.77
HEXO (HEXO) $1.429B 0.00
Cardiovascular Systems (CSII) United States $1.402B 1006.25
Phibro Animal Health (PAHC) United States $1.308B 18.80
VAREX IMAGING (VREX) United States $1.299B 25.44
AtriCure (ATRC) United States $1.104B 0.00
Lantheus Holdings (LNTH) United States $0.968B 26.15
MacroGenics (MGNX) United States $0.967B 0.00
Cerus (CERS) United States $0.885B 0.00
PetIQ (PETQ) United States $0.872B 24.96
Omeros (OMER) United States $0.868B 0.00
NanoString Technologies (NSTG) United States $0.753B 0.00
Meridian Bioscience (VIVO) United States $0.727B 21.67
OraSure Technologies (OSUR) United States $0.713B 31.24
Eagle Pharmaceuticals (EGRX) United States $0.705B 23.99
Evolus (EOLS) United States $0.701B 0.00
TG Therapeutics (TGTX) United States $0.650B 0.00
Surmodics (SRDX) United States $0.618B 89.94
LeMaitre Vascular (LMAT) United States $0.614B 29.21
Quanterix (QTRX) United States $0.551B 0.00
BioLife Solutions (BLFS) United States $0.397B 163.54
Vapotherm (VAPO) United States $0.371B 0.00
Rockwell Medical (RMTI) United States $0.363B 0.00
Insys Therapeutics (INSY) United States $0.358B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.30
Owens & Minor (OMI) United States $0.284B 3.94
Bovie Medical (APYX) United States $0.264B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.257B 0.00
Cytosorbents (CTSO) United States $0.255B 0.00
Zynex (ZYXI) United States $0.143B 15.35
Fonar (FONR) United States $0.143B 7.64
Surface Oncology (SURF) United States $0.117B 0.00
Chimerix (CMRX) United States $0.102B 0.00
Female Health (VERU) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.097B 0.00
InfuSystems Holdings (INFU) United States $0.090B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 20.01
CAS Medical Systems (CASM) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Neurotrope (NTRP) United States $0.061B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Valeritas Holdings (VLRX) United States $0.036B 0.00
Senestech (SNES) United States $0.028B 0.00
Myomo (MYO) United States $0.022B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
NeuroMetrix (NURO) United States $0.009B 15.57